Plasticell company
Plasticell is a privately held biotechnology company using novel cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Plasticell aims to develop drugs by elucidating the biochemical mechanisms that control the proliferation and differentiation of stem cells, the master cells responsible for tissue development and repair.
Total Funding:
£4.2M
Headquarters:
London, England, United Kingdom
Funding Status:
N/A
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Venture - Series Unknown
Number Of Exists:
Venture - Series Unknown
Technology:
Regenerative Medicine
Investor Type:
Company
Investors Number:
1
Founded Date:
6-24
Industry:
Regenerative Medicine